Rise and Shine: What you need to know before the ASX opens
Link copied to
On Stockhead today, the radiology software play that is now a $2.7bn stock without raising a penny, everything you need to know about ASX silver stocks and CBD producers stuck in limbo as US regulators take a cautious approach.
Australia will get an important update on the federal government, with the release of its first economic update since the pandemic began. Full details of the government’s spending plans will be announced, after it flagged an extension to the JobKeeper program earlier this week.
The following companies are in trading halts and are expected to exit in the next two trading days:
Audinate Group (ASX:AU8) – capital raising
Invex Therapeutics (ASX:IXC) – response to EMA & FDA advise
EMVision Medical Devices (ASX:EMV) – capital raising
MGC Pharmaceuticals (ASX:MXC) – pre-clinical study results
Kalina Power (ASX:KPO) – capital raising
Talon Petroleum (ASX:TPD) – capital raising
Gold: $US1,868.50 ($2,615.40) (+1.40%)
Silver: $US22.99 (+3.24%)
Oil (WTI): $US41.81 (-0.36%)
Oil (Brent): $US44.22 (-0.23%)
Coal: $US53.97 (+0.35%)
Iron 62pc Fe: $US107.58 (-0.04%)
AUD/USD: $US0.7144 (+0.22%)
Bitcoin: $US9,373.31 (-0.12%)
Yesterday’s top story was a blast from the past, where we checked in on the 50 best performing small caps of 2017 to see how they’re tracking now.
Blockchain and infant formula were all the rage back then, but of the Top 50 stocks from Trump’s first year in office only eight have continued to make gains.
Also, be sure to check in at 10.20am each morning for our daily 10 at 10 column — a live summary of winners & losers at the opening bell.